Showing results (31-40 of 61) with videos related to
Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|July 9, 2024
A broadly-neutralizing antibody against <i>Ebolavirus</i> glycoprotein that potentiates the breadth and neutralization potency of other antibodiesFrancesca R Donnellan, Vamseedhar Rayaprolu, Pramila Rijal, et al.Npj Viruses|May 7, 2026
A broadly-neutralizing antibody against Orthoebolavirus glycoprotein that potentiates the breadth and neutralization of other antibodiesFrancesca R Donnellan, Vamseedhar Rayaprolu, Pramila Rijal, et al.Frontiers in Public Health|December 6, 2021
Seroprevalence of SARS-CoV-2 Infection in the Colombo Municipality Region, Sri LankaChandima Jeewandara, Dinuka Guruge, Inoka Sepali Abyrathna, et al.Nature Communications|January 19, 2023
Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2Kuan-Ying A Huang, Xiaorui Chen, Arpita Mohapatra, et al.Immunity, Inflammation and Disease|March 29, 2022
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individualsChandima Jeewandara, Inoka Sepali Aberathna, Laksiri Gomes, et al.Plos Pathogens|August 4, 2021
Correction: Protective porcine influenza virus-specific monoclonal antibodies recognize similar haemagglutinin epitopes as humansBarbara Holzer, Pramila Rijal, Adam McNee, et al.Immunology|June 25, 2022
Comparison of the immunogenicity of five COVID-19 vaccines in Sri LankaChandima Jeewandara, Inoka Sepali Aberathna, Saubhagya Danasekara, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2020
Establishment of a Pig Influenza Challenge Model for Evaluation of Monoclonal Antibody Delivery PlatformsAdam McNee, Trevor R F Smith, Barbara Holzer, et al.Plos Pathogens|March 4, 2021
Protective porcine influenza virus-specific monoclonal antibodies recognize similar haemagglutinin epitopes as humansBarbara Holzer, Pramila Rijal, Adam McNee, et al.Medrxiv : the Preprint Server for Health Sciences|November 3, 2021
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individualsChandima Jeewandara, Inoka Sepali Aberathna, Laksiri Gomes, et al.Pageof 7